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Purpose. Collet-Sicard syndrome is a very rare condition characterised by unilateral palsy of the IX–XII cranial nerves. It is
distinguishedfromVillaretsyndromebylack ofpresence ofsympathetic involvement. Currentliteraturecontains onlytwocases of
Collet-Sicard syndrome due to idiopathic internal jugular vein thrombosis. Methodand Results.We report the case of Collet-Sicard
syndrome in a 30-year-old man who presented with delayed development of XIth nerve dysfunction, due to internal jugular vein-
sigmoid sinus thrombosis. A multidisciplinary team approach was employed in the management of this patient. At three-month
followup, he had signiﬁcantly improved swallowing, and repeat computed tomography neck scan showed partial recanalisation
of the right internal jugular vein. Conclusion. In suspected Collet-Sicard syndrome, a focal primary lesion or metastasis to the
temporal bone must be excluded, and sigmoid-jugular complex thrombosis should be considered in the diﬀerential diagnosis.
Early recognition and treatment may result in signiﬁcant functional recovery.
1.Introduction
Venous thromboembolism has an annual incidence of 1 in a
1000 in developed countries [1]. It most commonly aﬀects
the lower extremity veins but can occur in any vein. The
veins in the head and neck region appear less susceptible
to thrombosis even in the presence of local causes due to
being valveless and gravity assists in emptying the veins
when in the upright position [1]. Causes include direct and
iatrogenic trauma, vascular causes including thrombosis and
malignancy [1]. With the advent of antibiotics and their
widespread use, there has been a marked fall in otogenic and
deep neck space infections [1]. Consequently, thrombosis
of internal jugular vein (IJV) is rare. This paper describes
a unique case of idiopathic IJV-sigmoid sinus thrombosis
resulting in Collet-Sicard syndrome (CSS) with delayed
presentation of the XIth cranial nerve (CN) dysfunction.
2.CaseReport
A 32-year-old man presented with a gradual onset, severe
right sided headache, which resolved spontaneously within
24 hours with the subsequent development of dysphagia,
dysphonia, and right-sided neck pain. He had a preceding
history of upper respiratory tract infection with frontal sinus
pain, fevers, and mucopurulent nasal discharge. He had
no signiﬁcant past medical or family history. He denied
any illicit drug abuse, was a non-smoker, and consumed
moderate alcohol.
On examination, the right neck was tender along the
deep cervical chain, but with no lymphadenopathy. His ears,
nose, and neck movements were normal. Examination of the
oropharynx and larynx revealed dysfunction of the right-
sided IXth, Xth, and XIIth CNs, with loss of right-sided gag
reﬂex, paralysis of right soft palate musculature with uvula
deviation to the left, a hypotonic right tongue with deviation
to the right on protrusion, and a right-sided vocal cord palsy
with pooling of saliva in the hypopharynx. The trapezius and
sternocleidomastoid (SCM) muscles were preserved with
normal strength, indicating the XIth CN was preserved. The
rest of neurological examination was normal. Audiometry
was also normal.
Routine blood investigations were normal including
white cell count and C-reactive protein. A mild lymphopenia2 International Journal of Otolaryngology
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Figure 1: CT neck with contrast showing a low attenuating
collection within the right carotid space, which demonstrates
peripheral ring enhancement (block arrow). The appearances are
suggestiveofanabscess.Nointracranialabnormalitywasidentiﬁed.
R
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Figure 2: MR neck with contrast demonstrating focal thrombus
within the most superior part of the right internal jugular vein
and extending through the jugular foramen into the sigmoid sinus
(striped arrow). No evidence of deep cerebral venous thrombosis
was noted.
was noted on admission and subsequent testing for HIV
proved to be negative. A computed tomography (CT) scan
of the neck suggested an abscess in the right carotid space
ascending into the jugular foramen (Figure 1). However,
magnetic resonance imaging (MRI) conﬁrmed it to be
a focal thrombus within the most superior part of the
right IJV extending through the jugular foramen into the
sigmoid sinus (Figure 2). There was no deep cerebral venous
thrombosis.
Following discussion with a microbiologist, a two-week
course of intravenous clindamycin and ceftriaxone were
commenced to treat a possible infective cause. Following a
ﬁbreoptic endoscopic evaluation of swallowing (FEES), he
wasplacednilbymouthandnasogastricfeedingcommenced
as silent aspiration was noted. Speech and language therapy
were involved in the assessment and rehabilitation. Causes
for the thrombosis were sought, in particular neoplastic
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Figure 3: CT neck with contrast at three-month followup showing
that a focal ﬁlling defect consistent with thrombus is noted in
the distal sigmoid sinus on the right side extending into the right
internal jugular vein up to the level of C2 vertebra. There is partial
recanalisation of the previously thrombosed segment of the right
internal jugular vein (notched arrow). Normal appearances of the
internal carotid artery and internal jugular vein on the left side are
shown.
c a u s e sv i at u m o u rm a r k e r s ,a n daC Ts c a no ft h et h o r a x ,
abdomen, and pelvis proved normal. Investigations for
connectivetissueandvasculiticcauseswerenegativeandtests
for an underlying thrombophilia were normal except for a
weakly positive lupus anticoagulant. He was subsequently
anticoagulated. Following a repeat FEES, a safe swallow was
observed and he was discharged on oral diet with outpatient
followup.
At six-week followup, he had no resolution of the CN
palsies but had also developed CN XI palsy with a reduction
in right shoulder strength and atrophy of trapezius and SCM
on the right. This conﬁrmed the development of CSS, with
the dysfunction of CN IX–XII. At three months followup, he
had signiﬁcantly improved swallowing, and repeat CT neck
showed partial recanalisation of right IJV (Figure 3).
3. Discussion
Thrombosis of the IJV is an uncommon condition that may
lead to fatal complications. The most serious recognised
complications are pulmonary emboli with an incidence of
5% [2], and in the presence of infection, septic embolisation.
The leading causes of IJV thrombosis are iatrogenic trauma
due to jugular venous catheterisation, cardiac pacemaker
implantation, repeated venous access by IV drug abusers,
and surgery involving the neck [2]. Other causes include
malignancy, both primary and metastatic, deep space neck
infections, ovarian hyperstimulation in assisted conception
therapy [3, 4], and hypercoagulable disorders. Prior studies
have observed as much as a 30%–54% incidence of hyperco-
agulable state in patients with upper extremity deep venous
thrombosis (DVT) [5–8].
Headache complicates approximately 80% of cerebral
venous sinus thrombosis [9] as in this case with sigmoidInternational Journal of Otolaryngology 3
sinus involvement. Thrombosis of the sigmoid-jugular com-
plex is frequently asymptomatic because the venous drainage
system of the brain has suﬃcient alternative routes or
pathways. Blockage of the cerebral venous drainage through
the jugular foramen can cause raised intracranial pressure,
which can lead to epileptic seizures, however, in our case the
presentation was of unilateral palsy of lower CNs.
Multiple CN palsies are often a diagnostic challenge
because the nerves can be aﬀected at any site along their
course. In our case, CN IX–XII were involved which
suggested a pathological process located near the jugular
foramen. This foramen courses anterolaterally as it exits the
skullbaseandconsistsofasmalleranteromedialportion(the
pars nervosa) and a larger posterolateral portion (the pars
vascularis) that are separated by a complete or incomplete
ﬁbrous or bony septum. The pars nervosa contains CN IX–
XI, the inferior petrosal sinus, and the meningeal branch of
theascendingpharyngealartery.Theparsvasculariscontains
the sigmoid-jugular complex. The jugular foramen varies
g r e a t l yi ns i z e ,b u ta v e r a g e s1 5 m mi nl e n g t ha n d1 0 m m
in width [10]. In two thirds of cases, the right jugular
foramen is larger than the left [10] and is presumed to have
some relationship with the dominance of right cerebral sinus
drainage. It is interesting to note in this case that CN XI was
initially spared.
Involvement of the jugular foramen region leading to
lowerCNinvolvementischaracterisedbyseveraleponymous
syndromes, where because of their close anatomical relation-
ship multiple CN involvement is the rule (Table 1).
Vernet’s syndrome is characterised by a unilateral paral-
ysis of CN IX–XI and is due to a lesion inside the skull [11].
CSS refers to dysfunction of CN IX–XII and when this is
accompaniedbyanipsilateralHorner’ssyndromeitistermed
Villaret’s syndrome. CSS is due to extracranial causes but
intracranial pathology in theory could also occur [12, 13].
It usually suggests a posterior lacerocondylar space lesion,
where these nerves are closely related. CSS appears to be the
most likely syndrome related to this presentation despite the
initial sparing of the XIth CN.
Frederic Collet and Jean Sicard provided the original
descriptions of CSS based on posttraumatic cases during
World War I in which the location of the lesions was
demonstrated via radiographic studies as a result of the
presence of metallic fragments [12, 13]. Tumours of the
ear are the most common cause of CSS [14], but parotid
tumours, tumours of the skull base, metastases such as
prostate, kidney, breast, melanoma, multiple myeloma and
schwannomas of the hypoglossal nerve are also reported
[15]. Carcinomatous adenopathies and reticulosis such as
Hodgkin’s disease have also been reported [14]. Other
causes include vascular lesions such as carotid aneurysms
[16], jugular vein phlebitis, and especially glomus jugulare
tumours [14]. Iatrogenic causes include IJV catheterisation,
cerebral angiography, heart surgery, and cerebral vessel
clamping [16]a sw e l la ss u r g i c a le m p h y s e m as e c o n d a r y
to cryotherapy [17]. Other rarities reported include Lyme
disease, polyarteritis nodosa, haemangiopericytoma, idio-
pathic cranial polyneuropathy [15], and Trousseaus syn-
drome (migratory thrombophbitis associated with gastric
cancer) [1]. Spontaneous thrombophlebitis may be the ﬁrst
manifestationofoccultmalignancy.Inpatientswithaknown
malignancy developing features consistent with jugular fora-
men syndromes, this should always raise the possibility of
skull-base metastatic disease. The current literature has only
three reported cases of CSS as a result of venous thrombosis
[18–20]. This case is interesting, as initially it did not ﬁt
into one of the jugular foramen syndromes as CN XI was
initially spared. A possible reason for this has already been
hypothesised; this is due to the duality of vascularisation
between the internal and external branches of CN XI or due
to the duality of innervation of these muscles ensured by the
external branch of CN XI and C2-4 cervical spinal branches
[16].
In this case the cause of thrombosis of the IJV remains
unknown, not surprising as 20%–25% of cerebral venous
thrombosis have no known aetiology [21]. Despite the pre-
ceding symptoms suggesting an infective cause, the patient
remained apyrexial with normal inﬂammatory markers and
white cell count throughout. Imaging revealed no infective
or neoplastic focii. As preceding infection could not be
completely excluded as a cause, antibiotic treatment was
commenced in order to prevent septic complications. The
thrombophilia, connective tissue, and vasculitic screens were
negative, leading us to conclude that the cause of IJV
thrombosis in this case appears to be idiopathic. This is the
3rd reported case of CSS associated with IJV thrombosis,
but is certainly the ﬁrst case where the accessory nerve was
initially spared.
When investigating the cause of lower CN palsies,
consideration should be given to the previously dis-
cussed causes, that is, history of trauma, malignancy, or
thrombophilia. Complete examination should be performed
including testicular and breast examination as appropri-
ate. Tumour markers may also assist in directing further
investigation. A thrombophilia screen should be undertaken
in cases where thrombosis is suspected and evidence of
connective tissue and vasculitic disease should be sought.
Other investigations include audiometry, vestibular test-
ing and if necessary electrophysiological testing of the
CNs.
In terms of imaging, the most sensitive examination is
MRI in combination with magnetic resonance venography
[22]. T1 weighted and T2 weighted MRI will show a
hyperintense signal from the thrombosis. The characteristics
of the signal depend on the age of the thrombus and are
isointense on T1 weighted images during the ﬁrst ﬁve days
and after one month [22]. CT scanning is useful to rule out
other acute cerebral disorders and to show venous infarcts
or hemorrhages, but it can also be entirely normal. If the
diagnosis is still uncertain after MRI or CT venography,
conventional cerebral angiography may be indicated.
The poor level of evidence available confounds the man-
agement of internal jugular and cerebral sinus thrombosis.
Most of the literature relates to solitary case reports or small
case series, with no controlled studies due to their rarity.
As a result, there is no universal agreement or policy on
their management. Certainly a multidisciplinary approach
appears to be the key.4 International Journal of Otolaryngology
Table 1: Jugular Foramen and related syndromes.
Syndrome Neurological involvement
Vernet’s Syndrome CN IX, X, XI
Collet-Sicard Syndrome (posterior lacerocondylar space) CN IX, X, XI, XII
Villaret’s Syndrome (Retroparotid space) CN IX, X, XI, XII, sympathetic chain
Avellis’s Syndrome (Brain Stem) CN X, spinothalamic tract
Schmidt’s Syndrome CN X, spinal XI
Tapia’s Syndrome CN X, XII
Jackson’s Syndrome CN X, XI, XII
The traditional therapy for DVT is anticoagulation with
heparin followed by oral anticoagulation. This helps arrest
the thrombotic process and to prevent thromboembolic
events. Concerns over venous infarction, embolisation, and
persistent septic thrombophlebitis have led to recommen-
dations for anticoagulation in patients with sigmoid sinus
thrombosis. Embolism has been reported in several studies
with an incidence of 0%–33% with the lung being the most
frequently aﬀected site [23]. The rate of embolisation has
markedly decreased with the introduction and improvement
in antibiotics [23]. Bradley et al. suggest that patients with
thrombosisconﬁnedtothesigmoidsinusshouldnotbeanti-
coagulated to avoid the associated risks; they emphasise that
serial imaging with MRI, MR venography, or CT venography
is important in all patients to monitor thrombus progression
[23]. Criteria supporting anticoagulation include evidence
of thrombus progression, extension to other sites on initial
examination such as the proximal IJV, transverse sinus or
cavernous sinus, neurological changes, persistent fevers or
embolic events. Most studies and review articles examining
upper extremity DVT recommend anticoagulation therapy
[24]. This recommendation is largely based on the concern
of the possibility of fatal PE. The other, perhaps better,
recommended indication for anticoagulation therapy is to
reduce the incidence of postthrombotic syndrome [24].
Fibrinolytics are used less and less with surgery such as
thrombectomy or partial resection of the vessel being rare
nowadays unless it is associated with the surgical treatment
ofneoplasms[1].Aftertheacuteperiod,oralanticoagulation
with warfarin is typically used for 1–3 months, with a
desired INR target of 1.8–2.8. Then the patient is reevaluated
with CT or MRI and venography to determine if ﬂow has
been reestablished. Prolonged anticoagulant therapy may be
required for refractory cases or patients with an underlying
prothrombotic state [25].
The optimal management of any venous thrombosis
must be individualised and therefore depends on a patient’s
spectrum of concomitant illness, anticoagulation, bleed-
ing risk, and cardiopulmonary stability. Recent surgery,
trauma, active bleeding and thrombocytopenia can impart
an increased bleeding risk [26]. Sheikh et al. support the
use of low-molecular weight heparin in the acute setting
to prevent central propagation, symptomatic pulmonary
embolism and maintain any restored venous patency [26].
Superior vena caval ﬁlters may be appropriate in patients
with IJV thrombosis who are unable to receive anticoagula-
tion and whose cardiopulmonary status is deemed unlikely
to tolerate pulmonary embolism of any size [27].
Endovascular thrombolysis can be attempted with the
administration of a thrombolytic enzyme, usually urokinase.
Published reports are limited to case reports and uncon-
trolled studies, from which it is impossible to conclude
that the results associated with endovascular thrombolysis
are superior to those with systemic heparin [28]. Until
better evidence is available, endovascular thrombolysis may
be applied at centres where the staﬀ have experience in
interventional radiology, and this treatment method should
be restricted to patients with a poor prognosis. A future
randomizedtrialmaycomparetheeﬀectofheparinwiththat
of endovascular thrombolysis in high-risk patients.
4. Conclusion
Due to the complex nature of presentation, delay in diag-
nosis of CSS is not uncommon. In all cases of suspected
CSS, a focal primary lesion or metastatic disease to the
temporal bone must be excluded, as early recognition and
appropriate treatment may result in signiﬁcant clinical
improvement. Although IJV thrombosis is extremely rare,
it should be considered in the diﬀerential diagnosis. A
multidisciplinary approach to the management of the CSS
patient is paramount in achieving successful functional
recovery. This case highlights the importance of serial
clinical and radiological examinations in assessment of
clinical improvement and disease progression in patients
with conﬁrmed or suspected CSS.
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